SCN5A mutations in atrial fibrillation

Heart Rhythm

Volumn 7, Issue 12, 2010, Pages 1870-1871

  Amin, Ahmad S ^a   Bhuiyan, Zahurul A ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FLECAINIDE; POTASSIUM CHANNEL; SODIUM CHANNEL; SODIUM CHANNEL NAV1.5;

DRUG EFFICACY; DRUG INHIBITION; GENETIC ANALYSIS; HEART ARRHYTHMIA; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE EXCITABILITY; HEART RATE VARIABILITY; HEART REPOLARIZATION; HEART RHYTHM; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; LONG QT SYNDROME; LOSS OF FUNCTION MUTATION; NONHUMAN; NOTE; PRIORITY JOURNAL; QT PROLONGATION; RISK FACTOR;

EID: 78650084179     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2010.09.012     Document Type: Editorial

References (20)

1. S. Nattel New ideas about atrial fibrillation 50 years on Nature 415 2002 219 226
2. K. Shinagawa, Y.F. Shi, J.C. Tardif, T.-K. Leung, and S. Nattel Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs Circulation 105 2002 2672 2678
3. R. Zou, J. Kneller, L.J. Leon, and S. Nattel Substrate size as a determinant of fibrillatory activity maintenance in a mathematical model of canine atrium Am J Physiol Heart Circ Physiol 289 2005 H1002 H1012
4. A.S. Amin, H.L. Tan, and A.A. Wilde Cardiac ion channels in health and disease Heart Rhythm 7 2010 117 126
5. P.T. Ellinor, E.G. Nam, M.A. Shea, D.J. Milan, J.N. Ruskin, and C.A. MacRae Cardiac sodium channel mutation in atrial fibrillation Heart Rhythm 5 2008 99 105
6. T. Makiyama, M. Akao, and S. Shizuta A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation J Am Coll Cardiol 52 2008 1326 1334
7. v 1.5 in atrial fibrillation enhances cellular excitability and lowers the threshold for action potential firing Biochem Biophys Res Commun 380 2009 132 137
8. N. Toh, H. Morita, and S. Nagase Atrial electrophysiological and structural remodeling in high-risk patients with Brugada syndrome: assessment with electrophysiology and echocardiography Heart Rhythm 7 2010 218 224
9. B. Benito, R. Brugada, and R.M. Perich A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation Heart Rhythm 5 2008 1434 1440
10. S. Zellerhoff, R. Pistulli, and G. Mnnig Atrial Arrhythmias in long-QT syndrome under daily life conditions: a nested case control study J Cardiovasc Electrophysiol 20 2009 401 407
11. A. Blana, S. Kaese, and L. Fortmller Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability Heart Rhythm 7 2010 1862 1869
12. + channel-linked long-QT syndrome Circ Res 78 1996 916 924
13. + channel blockade and to increases in heart rate Implications for gene-specific therapy Circulation 92 1995 3381 3386
14. T. Nagatomo, C.T. January, B. Ye, H. Abe, Y. Nakashima, and J.C. Makielski Rate-dependent QT shortening mechanism for the LQT3 ΔKPQ mutant Cardiovasc Res 54 2002 624 629
15. P. Kirchhof, L. Eckardt, and G. Mnnig A patient with "atrial torsades de pointes." J Cardiovasc Electrophysiol 11 2000 806 811
16. P. Kirchhof, L. Eckardt, and M.R. Franz Prolonged atrial action potential durations and polymorphic atrial tachyarrhythmias in patients with long QT syndrome J Cardiovasc Electrophysiol 14 2003 1027 1033
17. C antiarrhythmic flecainide Mol Pharmacol 57 2000 101 107
18. A.J. Moss, J.R. Windle, and W.J. Hall Safety and efficacy of flecainide in subjects with long QT-3 syndrome (ΔKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial Ann Noninvasive Electrocardiol 10 2005 59 66
19. + channel expression and cardiac conduction Pflgers Arch 460 2010 593 601
20. Y. Dautova, Y. Zhang, I. Sabir, A.A. Grace, and C.L. Huang Atrial arrhythmogenesis in wild-type and Scn5a+/Δ murine hearts modelling LQT3 syndrome Pflgers Arch 458 2009 443 457